Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$187.64 - $206.25 $37,528 - $41,250
-200 Reduced 0.83%
24,040 $4.63 Million
Q1 2023

May 15, 2023

BUY
$127.59 - $203.08 $12,759 - $20,308
100 Added 0.41%
24,240 $4.91 Million
Q4 2022

Feb 15, 2023

SELL
$117.37 - $139.17 $23,474 - $27,833
-200 Reduced 0.82%
24,140 $3.1 Million
Q3 2022

Nov 14, 2022

BUY
$135.27 - $180.11 $40,581 - $54,033
300 Added 1.25%
24,340 $3.33 Million
Q1 2022

May 13, 2022

SELL
$119.61 - $157.85 $11,961 - $15,785
-100 Reduced 0.41%
24,040 $3.46 Million
Q3 2021

Nov 16, 2021

SELL
$142.45 - $169.82 $185,184 - $220,766
-1,300 Reduced 5.11%
24,140 $4.1 Million
Q2 2021

Aug 16, 2021

BUY
$135.08 - $161.1 $148,588 - $177,210
1,100 Added 4.52%
25,440 $4.02 Million
Q1 2021

May 17, 2021

SELL
$137.51 - $190.8 $151,261 - $209,880
-1,100 Reduced 4.32%
24,340 $3.38 Million
Q4 2020

Feb 16, 2021

BUY
$164.63 - $211.93 $4.19 Million - $5.39 Million
25,440 New
25,440 $4.46 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Utah Retirement Systems Portfolio

Follow Utah Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.